Literature DB >> 18178610

Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis.

N Viget1, G Vernier-Massouille, D Salmon-Ceron, Y Yazdanpanah, J-F Colombel.   

Abstract

Because of the increasing use of immunosuppressive and biological drugs, the occurrence of opportunistic infections has become a key safety issue for patients with inflammatory bowel disease (IBD). Consequently, improvement of healthcare workers' knowledge of this domain is urgent. In this review, the preventive measures that would help to reduce the rate of opportunistic infections in patients with IBD are listed, and the management of situations frequently confronting doctors is considered. In the absence of national and international recommendations, the information given here should help doctors to optimise patient outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178610     DOI: 10.1136/gut.2006.114660

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  47 in total

1.  Negative effect of immunosuppressive therapy in the performance of the QuantiFERON gold in-tube test in patients with immune-mediated inflammatory diseases.

Authors:  José M Ramos; Mar Masiá; Juan C Rodríguez; Cristina López; Sergio Padilla; Catalina Robledano; Francisco J Navarro-Blasco; Jaime Matarredona; Mariana F García-Sepulcre; Félix Gutiérrez
Journal:  Clin Exp Med       Date:  2012-06-27       Impact factor: 3.984

2.  Anti-tumor necrosis factor therapy and influenza: keeping it in perspective.

Authors:  Matt Shale; Markus Czub; Gilaad G Kaplan; Remo Panaccione; Subrata Ghosh
Journal:  Therap Adv Gastroenterol       Date:  2010-05       Impact factor: 4.409

3.  Elevated risk of opportunistic viral infection in patients with Crohn's disease during biological therapies: a meta analysis of randomized controlled trials.

Authors:  Xiaobing Wang; Feng Zhou; Junzhang Zhao; Rui Zhou; Meifang Huang; Jin Li; Wei Wang; Shufang Xu; Bing Xia
Journal:  Eur J Clin Pharmacol       Date:  2013-07-25       Impact factor: 2.953

4.  IBD: incidence of HSV and HPV with azathioprine.

Authors:  Mario Cottone; Sara Renna
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08       Impact factor: 46.802

Review 5.  Medical management of Crohn's disease.

Authors:  J R Fraser Cummings; Satish Keshav; Simon P L Travis
Journal:  BMJ       Date:  2008-05-10

6.  Vaccinations and the Utilization of Immunosuppressive IBD Therapy.

Authors:  Gil Y Melmed
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-12

7.  Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial.

Authors:  Hiroko Matsumoto; Satoko Ohfuji; Kenji Watanabe; Hirokazu Yamagami; Wakaba Fukushima; Kazuhiro Maeda; Noriko Kamata; Mitsue Sogawa; Masatsugu Shiba; Tetsuya Tanigawa; Kazunari Tominaga; Toshio Watanabe; Yasuhiro Fujiwara; Yoshio Hirota; Tetsuo Arakawa
Journal:  J Gastroenterol       Date:  2015-02-12       Impact factor: 7.527

Review 8.  Current therapy of pediatric Crohn's disease.

Authors:  Avishay Lahad; Batia Weiss
Journal:  World J Gastrointest Pathophysiol       Date:  2015-05-15

9.  Inflammatory bowel disease in travelers: choosing the right vaccines and check-ups.

Authors:  Maria Esteve; Carme Loras; Ester García-Planella
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 10.  Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis.

Authors:  Pilar López-Serrano; Jose Lázaro Pérez-Calle; Maria Dolores Sánchez-Tembleque
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.